FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to therapy and cardiology, and concerns treating cardiac valve disease of a chlamydial aethiology. That is ensured by the laboratory retest for chlamydia following the course of common anti-chlamydia therapy. If the laboratory retest shows the presence of infection, an additional session of chemotherapy is required by introducing the preparation macmiror 400 mg. The preparation is taken according to the schedule: 2 tablets in the morning at 8 am and in the evening at 8 pm for 10-12 days, with a 15-day pause; then taken for 10-12 days with another 15-day pause, and another 10-12 days of taking the tablets.
EFFECT: method provides the effective treatment of cardiac valve disease of a chlamydial aethiology ensured by eliminating an aethiological factor of the disease.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF COMPLICATED UROGENITAL CLAMIDIOSIS | 2007 |
|
RU2361595C1 |
METHOD OF TREATING CHRONIC URETHROPROSTATITIS WITH CHLAMYS AND UREA- MYCOPLASMA ETIOLOGY | 1999 |
|
RU2140307C1 |
METHOD OF DIFFERENTIALLY DIAGNOSING COMPLICATIONS IN MEN SUFFERING FROM UROGENITAL CHLAMIDIOSIS | 2005 |
|
RU2307352C2 |
METHOD FOR DIAGNOSIS OF CHRONIC INFECTIOUS-INFLAMMATORY VASCULAR LESIONS OF CENTRAL NERVOUS SYSTEM ASSOCIATED WITH CHLAMYDIAL INFECTION | 2008 |
|
RU2394244C2 |
METHOD FOR TREATING UROGENITAL CHLAMYDIAL INFECTION | 2005 |
|
RU2302265C1 |
METHOD FOR TREATING CHLAMYDIA-CAUSED PROSTATITIS CASES | 2006 |
|
RU2307656C1 |
DIAGNOSTIC TECHNIQUE FOR PERSISTENT LATENT BACTERIAL INFECTION WITH ASSOCIATING VESSEL WALL INVOLVEMENT | 2009 |
|
RU2414714C1 |
METHOD FOR RESTORING AND KEEPING FAMILY HEALTH | 2002 |
|
RU2230558C2 |
METHOD OF DIAGNOSTICS OF CHLAMYDIAL UROGENITAL INFECTION IN MEN | 2018 |
|
RU2683024C1 |
METHOD FOR TREATING DISEASES OF ENT ORGANS OF CHLAMYDIAL ETIOLOGY IN CHILDREN | 2017 |
|
RU2697977C1 |
Authors
Dates
2013-09-10—Published
2010-08-31—Filed